Inhibition of Zinc Metallopeptidases in Cardiovascular Disease - From Unity to Trinity, or Duality?

E-ISSN： 1873-4286|15|31|3606-3621

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.15, Iss.31, 2009-11, pp. : 3606-3621

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Endothelin System in Cardiovascular Disease and the Potential Therapeutic Perspectives of its Inhibition

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 95-114

Bentham Science Publishers

Access to resources Recommend Favorite

The Promise of Cholesteryl Ester Transfer Protein (CETP) Inhibition in the Treatment of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 19, Iss. 17, 2013-05 ,pp. : 3143-3149

Bentham Science Publishers

Access to resources Recommend Favorite

Xanthine Oxidase and its Role as Target in Cardiovascular Disease: Cardiovascular Protection by Enzyme Inhibition?

Current Pharmaceutical Design, Vol. 23, Iss. 23, 2017-09 ,pp. : 3391-3404

Bentham Science Publishers

Access to resources Recommend Favorite

Phytochemicals from Plants to Combat Cardiovascular Disease

Current Medicinal Chemistry, Vol. 19, Iss. 14, 2012-05 ,pp. : 2242-2251

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNA-21: From Cancer to Cardiovascular Disease

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 926-935

Bentham Science Publishers

Access to resources Recommend Favorite